GWM
NAGE

Geneos Wealth Management’s Niagen Bioscience NAGE Stock Holding History

Geneos Wealth Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,950
Closed -$27K – 2917
2021
Q2 		$27K Sell
2,950
-1,500
-34% -$13.1K ﹤0.01% 1769
2021
Q1 		$39K Buy
4,450
+1,000
+29% +$7.93K ﹤0.01% 1764
2020
Q4 		$31K Buy
+3,450
New +$16.8K ﹤0.01% 1692

Other funds holding NAGE

YRHAM
Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Geneos Wealth Management's NAGE Position: Q3 2021 in Review

Geneos Wealth Management sold out of Niagen Bioscience (NAGE) in Q3 2021, closing a stake of 2,950 shares — an estimated $27K sold.

Geneos Wealth Management first reported a position in NAGE in Q4 2020 and held it in 3 quarters. The position peaked at $39K in Q1 2021. 86 funds tracked by Wall St. Rank hold NAGE as of Q3 2021.

  • Geneos Wealth Management reported no remaining Niagen Bioscience position as of Q3 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 2,950 Niagen Bioscience shares in Q3 2021, an estimated $27K.
  • Geneos Wealth Management first reported a position in Niagen Bioscience in Q4 2020 and held it in 3 quarters.
  • Geneos Wealth Management's Niagen Bioscience position peaked at $39K in Q1 2021.
  • 86 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2021.

Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.